×
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT

Jubilant Pharma completes studies using novel oral formulation of Remdesivir

Jubilant has sought authorisation for additional studies for this novel oral formulation from the Drug Controller General of India
Last Updated : 19 April 2021, 11:28 IST

Follow Us :

Comments
ADVERTISEMENT
Published 19 April 2021, 11:17 IST

Follow us on :

Follow Us